A new blood group antigen is defined by anti‐<scp>CD</scp>59, detected in a <scp>CD</scp>59‐deficient patient
Markus Anliker(German Red Cross), Christof Weinstock(Universität Ulm), Hubert Schrezenmeier(German Red Cross), Britta Höchsmann(German Red Cross), Christian Dohna‐Schwake(Essen University Hospital), Willy A. Flegel(National Institutes of Health Clinical Center), Inge von Zabern(German Red Cross), Henriette Kyrieleis(Krankenhaus Bethanien)
Cited by 28
Related Papers
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
|Blood|2007|653
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
|Blood|2007|578
Molecular Basis of Weak D Phenotypes
|Blood|1999|336
Molecular Basis of Weak D Phenotypes
|Blood|1999|331